A Dark Vector Cognition product

Item 5. Other Information.

2K characters. Original on sec.gov ·

Item 5. Other Information.

(c) Insider Trading Arrangements

During the third quarter 2024, certain executive officers and a director entered into Rule 10b5-1 trading arrangements that are intended to satisfy the affirmative defense of Rule 10b5-1(c). The executive officers’ plans provide for: i) the sale of all of the shares upon vesting pursuant to certain outstanding equity awards previously granted to the applicable executive officer, excluding any shares withheld by the company to satisfy tax withholding obligations (see the 2024 Proxy Statement for a description of the company’s equity compensation plans) and, ii) for one executive, the sale of a certain amount of additional shares (see “Additional or Specified Shares” below) held by the applicable executive, that are not sold in connection with the vesting of an outstanding equity award (as described in i) above), some of which may have been the result of a prior vesting event for the executive. The director’s plan provides for the sale of a specified amount of shares held by the director, some of which may have been the result of a prior vesting event.

Below are the details of each applicable Rule 10b5-1 trading arrangement:

NameTitleDate EnteredDate Expires****1Additional or Specified Shares
Officers
Karen B. BailoCommercial Lines PresidentSeptember 24, 2024December 31, 20250
Mariann Wojtkun MarshallVice President and Chief Accounting OfficerAugust 19, 2024August 13, 20250
John P. SauerlandVice President and Chief Financial OfficerAugust 22, 2024August 29, 202580,000
Directors
Jeffrey D. KellyDirectorSeptember 24, 2024June 30, 202510,000

1 Subject to the plan’s earlier expiration or completion in accordance with its terms.

Additional Information

President and CEO Susan Patricia Griffith’s quarterly letter to shareholders is included as Exhibit 99 to this Quarterly Report on Form 10-Q and in our online shareholders’ report located on our investor relations website at: investors.progressive.com/financials.

Previous: Item 1A. Risk Factors. · Next: Item 6. Exhibits.